Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3403314
Max Phase: Preclinical
Molecular Formula: C34H53BrN6O7
Molecular Weight: 737.74
Molecule Type: Small molecule
Associated Items:
ID: ALA3403314
Max Phase: Preclinical
Molecular Formula: C34H53BrN6O7
Molecular Weight: 737.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)C(=O)[C@H](Cc1ccc(Br)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](N)COC(=O)[C@@H]1CCCN1C(C)=O)C(C)C
Standard InChI: InChI=1S/C34H53BrN6O7/c1-8-40(9-2)33(46)27(18-23-12-14-24(35)15-13-23)38-31(44)26(17-20(3)4)37-32(45)29(21(5)6)39-30(43)25(36)19-48-34(47)28-11-10-16-41(28)22(7)42/h12-15,20-21,25-29H,8-11,16-19,36H2,1-7H3,(H,37,45)(H,38,44)(H,39,43)/t25-,26-,27-,28-,29-/m0/s1
Standard InChI Key: YJGNWSYDXOZQKI-ZIUUJSQJSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 737.74 | Molecular Weight (Monoisotopic): 736.3159 | AlogP: 1.90 | #Rotatable Bonds: 17 |
Polar Surface Area: 180.24 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.82 | CX Basic pKa: 7.22 | CX LogP: 1.86 | CX LogD: 1.64 |
Aromatic Rings: 1 | Heavy Atoms: 48 | QED Weighted: 0.18 | Np Likeness Score: -0.40 |
1. Zhen XL, Yin WH, Tian X, Ma ZJ, Fan SM, Han JR, Liu S.. (2015) Synthesis and biological evaluation of open-chain analogs of cyclic peptides as inhibitors of cellular Shp2 activity., 23 (10): [PMID:25865131] [10.1016/j.bmc.2015.03.035] |
Source(1):